Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q4 FY23 results · Jan–Mar 2023
Camlin Fine Sciences reported revenue from operations of ₹426.71 crore (up 9.6% from Q4 FY22) and net profit of ₹3.48 crore (down 73.9% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 426.71 | 389.23 | +9.6% | 387.84 | +10.0% |
| Other income | 2.00 | 21.32 | −90.6% | 9.76 | −79.6% |
| Total income | 428.70 | 410.54 | +4.4% | 397.60 | +7.8% |
| Profit before tax | 8.43 | 19.95 | −57.7% | 31.79 | −73.5% |
| Net profit for the period | 3.48 | 13.33 | −73.9% | 22.86 | −84.8% |
| Attributable to shareholders of the company | 9.16 | 15.13 | −39.5% | 24.04 | −61.9% |
| EPS, basic (₹) | 0.59 | 1.16 | −49.1% | 1.53 | −61.4% |
| Net margin (%) | 0.8 | 3.4 | 5.9 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 218.16 | 201.39 | +8.3% | 172.69 | +26.3% |
| Other income | 1.24 | 7.56 | −83.6% | 11.02 | −88.8% |
| Total income | 219.40 | 208.95 | +5.0% | 183.71 | +19.4% |
| Profit before tax | 11.44 | 22.06 | −48.2% | 19.34 | −40.9% |
| Net profit for the period | 7.80 | 15.75 | −50.4% | 15.79 | −50.6% |
| EPS, basic (₹) | 0.51 | 1.21 | −57.9% | 1.01 | −49.5% |
| Net margin (%) | 3.6 | 7.8 | 9.1 |
Consolidated
- Filed with BSE
- 23 May 2023, 14:15 IST
- Board meeting
- 22 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 23 May 2023, 14:15 IST
- Board meeting
- 22 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE